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The Expression of Hepatoma Upregulated Protein in Human 




Human endometrium resists embryo implantation except during the window period. 
Currently, uterine HURP expression is known to be involved in endometrial stromal 
proliferation during embryo implantation of mice. Thus, we demonstrated hepatoma up-
regulated protein (HURP) expression in the human endometrium during the menstrual 
cycle, as well as HURP regulation in endometrial stromal cells (ESCs). 
Materials and Methods 
We collected human endometrial samples from different menstrual cycle phases 
(early/late proliferative, and early/mid/late secretory), and then analyzed these samples 
by immunohistochemistry, reverse transcription-polymerase chain reaction, and 
Western blotting. We also assessed the effects of two sex-steroid hormones, 17β-
estradiol (E2) and 4-pregnene-3,20-dione (P4) on the cultured stromal cells. 
Results 
HURP protein was localized to the nucleus of the endometrial both epithelial and 
stromal cells in all stages. Also, HURP mRNA and protein in human endometrial tissue 
was significantly up-regulated during late-proliferative and secretory phase, compared 
with early-proliferative phase. In ESCs, HURP expression was regulated by E2, but not 
P4. 
Conclusions 
We indicated that cyclic changes in HURP expression in human normal ESC strongly 
suggested up-regulation by estrogen. Taken together, since estrogen responses are 
fundamental in endometrial biology, uterine expression of HURP may be involved in 
female reproductive function during menstrual cycle. 
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Introduction 
A satisfactory reproductive outcome requires synchronous growth and maturation of the 
endometrium throughout the menstrual cycle. Dynamic changes occur in the human 
endometrium during the menstrual cycle under the influence of estrogen and 
progesterone. Each phase of the menstrual cycle is precisely tuned by many known and 
unknown genes that are regulated by endocrine, paracrine, and autocrine factors. 
Appropriate endometrial changes are essential for successful embryo implantation. An 
aberrant endometrial status may lead to implantation failure.  
Previous reports determined that hepatoma upregulated protein (HURP), a cell 
cycle-associated gene, affects endometrial stromal proliferation during implantation [1-
7]. Loss of HURP expression in the endometrium led to an implantation defect and 
infertility [7]. The aforementioned indicates that HURP may have structural and 
functional roles in the female reproductive tract. However, current knowledge regarding 
HURP’s role in the endometrium is mostly derived from research on malignant tissues 
[1,7–12]. As such, the regulation and possible roles of HURP in human endometrium 
are uncertain.  
This study further defined the role of HURP in human endometrium by 
characterizing changes in HURP mRNA and protein abundance, as well as the cellular 
and subcellular localization of HURP protein over the normal human menstrual cycle. 
In addition, we examined the effect of the steroid hormones E2 and P4 on the 
expression of HURP in endometrial stromal cells. 
 
Materials and Methods 
Patients and samples 
Endometrial tissue was obtained from 52 women, either by curettage under sterile 
conditions or during hysterectomy for benign gynecologic diseases. Samples were 
collected at the time of hysterectomy, laparoscopic sterilization, or hysteroscopy. Tissue 
samples were divided into five groups, based on well-established criteria, for the 
evaluation of mRNA and protein [13]: early-proliferative (n = 12), late-proliferative (n 
= 14), early-secretory (n = 9), mid-secretory (n = 9), and late-secretory phase (n = 8). 
Fresh tissue was obtained from biopsy samples and stored at –70°C for Western 
blotting. It was obtained from biopsies and stored in RNAlater® (Ambion, Austin, TX, 
USA), according to the manufacturer’s instructions for real-time polymerase chain 
reaction (RT-PCR). The mean (± standard deviation) age of the women was 35.61 ± 
7.21 years. All women had regular menstrual cycles, which ranged from 25 to 35 days, 
and none received hormonal treatment within the 6 months prior to surgery. The 
experimental procedures were approved by the Institutional Review Board at the Shiga 
University of Medical Science (approval number 23-72-1). All women provided written 
informed consent for the use of their endometrial tissues. 
 
Immunohistochemistry 
Immunohistochemical staining for was undertaken using the streptavidin-biotin 
peroxidase (ABC) method using the VECTASTAIN ABC Kit (Vector Laboratories, 
Burlingame, CA)  for peroxidase (rabbit IgG) (Vector laboratories, Burlingame, USA) 
according to the manufacturer's protocol with rabbit polyclonal anti-human HURP 
antibody (ab5068, Abcam, Cambridge, MA, UK) at a dilution of 1 out of 200 in 
TBS/20% swine serum (SS). DAB (Vector Laboratories) were used to visualize the 
bound antibody. Sections were counterstained with Harris hematoxylin. Negative 
controls were used to block peptides (ab111970, Abcam). 
 
Isolation and culture of human endometrial stromal cells 
Human human endometrial stromal cells (ESCs) were isolated and cultured as 
previously described [14]. At first passage, the cells were plated in 6-well culture plates 
(Becton Dickinson) at a density of 1×105 cells/mL. Cells were cultured with 4-mL 
DMEM supplemented with 10% charcoal-stripped fetal bovine serum, 1% antibiotics 
(Life Technologies), and some other materials, including 17β-estradiol (E2; Sigma) and 
4-pregnene-3,20-dione (P4; Sigma) at 48 h.  
 
Western blot analysis 
Expression of HURP protein was analyzed by Western blotting as previously described 
[15]. The primary antibodies used included rabit polyclonal human anti HURP antibody 
(1:2000) and GAPDH (1:5000). The ECL Western Blotting Detection System was used 
to detect signals, which were visualized using LAS-4000 mini (GE Healthcare, Little 
Chalfont, UK). Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) was used as the 
loading control. 
 
Total RNA extraction and quantitative real-time PCR 
Total RNA was extracted from the samples and purified using TRIzol Reagent with the 
PureLink™ Mini Total RNA Purification System (Invitrogen, Carlsbad, CA, USA), 
according to the manufacturer’s instructions. The PrimeScript RT Reagent Kit (Takara 
Bio, Shiga, Japan) was used to synthesize complementary DNA. PCR samples were 
prepared up to a final volume of 20 μL using 1× SYBR Green Master Mix (Roche, 
Laval, Canada). Primer sequences used were 5′- 
GAAAGCAGGAGCAGCATAGAAGA-3′ (sense) and 5′- 
CACCAGCAAGAAGAGGCAAAC-3′ (antisense) for HURP and 5′-
AAATCCCATCACCATCTTCCA-3′ (sense) and 5′-AATGAGCCCCAGCCTTCTC-3′ 
The PCR cycling conditions were as follows: 95 °C for 5 min amplification, 40 cycles 
of 94°C for 15 s, 60°C for 45 s, and 72°C for 10 s on the Roche LC480 system (Roche) 
Cycle threshold (Ct) values were used to compute levels of mRNA expression from the 
standard curve. Analytical data were adjusted based on the mRNA expression of 
GAPDH as an internal control. 
 
Statistical analysis 
Since the data from Western blot and mRNA analyses in the endometrium were not 
normally distributed, they were analyzed via nonparametric analysis of variance on 
ranks (Kruskal–Wallis test). SPSS ver. 20 (SPSS Inc., Chicago, IL, USA) was used to 
perform statistical calculations. Statistical significance was defined as P <0.05. 
 
Results 
Localization of HURP expression in human endometrium using 
immunohistochemistry 
We analyzed tissue sections at different phases of the menstrual cycle (early-, late-
proliferative phase or early-, mid-, late-secretory phase), using immunohistochemistry 
with an anti-HURP antibody, to assess the subcellular localization of expression of 
HURP in the endometrial tissue. Immunohistochemistry studies showed diffuse staining 
in the nucleus of the endometrial epithelial and stromal cells in all stages. Endometrial 
HURP was weakly expressed in the nucleus of endometrial stromal cells in the early-
proliferative phase than in the other phases. In addition, HURP was highly expressed in 
the mid- and late-secretory phases in the glandular epithelial cells when compared to the 
other stages (Figure 1). From above, HURP was expressed in both endometrial stromal 
cells and epithelial cells of human endometrium. 
 
Pattern of endometrial HURP expression 
We divided the endometrial tissues into five groups, early-proliferative, late-
proliferative, early-secretory, mid-secretory, and late-secretory phase, according to the 
most recent menstrual period and histology according to the criteria of Noyes et al. [16]. 
Figure 2 shows that the relative expression of the HURP mRNA level in endometrial 
tissues peaked in the late-proliferative phase. The expression was also significantly 
higher in the late-proliferative phase than that in the late-secretory phase. Furthermore, 
HURP mRNA was downregulated during the early-, mid-, and late- secretory phases of 
the menstrual cycle. In accordance with mRNA levels, the protein level of HURP was 
significantly upregulated during the late-proliferative phase of the menstrual cycle than 
during the early-proliferative phase. Unlike the expression of HURP mRNA during the 
secretory phase, the expression of HURP protein levels decreased rapidly in the mid-
secretory phase. These results confirm and extend previous murine observations by 
significantly increasing the sample number and using a histopathological classification 
instead of a molecular classification of the menstrual cycle. 
 
Steroid hormone regulation of HURP protein expression 
We assessed the effects of sex steroid hormones on the regulation of HURP in early-
proliferative endometrial stromal cells after 48 h. HURP protein expression was 
significantly stronger in explants cultured with E2 alone than with the control, P4, and 
E2 and P4 (Figure 3A, 3B). There were no significant differences in HURP protein 
expression between the other groups. A panel of chemicals comprising of E2 and P4 
was also applied to ESCs at increasing concentrations (E2: 10-9 M to 10-7 M and P4: 10-
7 M to 10-5 M). A significant increase in the expression of HURP protein was observed 
in cells treated with E2 at 10-8 and 10-7M than with controls (Figure 3C, 3D). However, 
we observed no change in the expression of HURP protein cultured with P4 than with 
controls. Therefore, HURP expression was regulated by E2, but not by P4. 
 
Discussion 
The present study showed that the expression of HURP in the endometrium 
dynamically changes with the menstrual cycle. Also, E2 increased HURP expression in 
cultured endometrial stromal cells, whereas P4 suppressed its expression. Previous 
reports revealed that estrogen upregulated HURP expression in murine endometrial 
stromal cells and that HURP deficiency in murine endometrium was involved in 
implantation defects [7]. Therefore, this finding supports the possibility that HURP 
expression may also be associated with impaired implantation in humans. 
 The present study provides comprehensive information about the dynamic 
endometrial expression of HURP in the subsequent phases of the same menstrual cycle. 
A previous study determined that HURP expression was regulated by sex steroid 
hormones in the murine uterus [13]. The cyclic changes in the endometrium are 
important for implantation. It is well known that the maturation of the endometrium is 
important for successful embryo implantation [17,18]. Our results showed the presence 
of HURP in human endometrium, with an increase in HURP expression in the late-
proliferative phase compared with the early-proliferative phase. The mRNA and protein 
levels of HURP expression have been maintained in the secretory phase. On the other 
hand, it has been reported that HURP protein is expressed only in murine endometrial 
stromal cells [13]. However, we interestingly confirmed that HURP protein was 
expressed in both endometrial gland epithelial and stromal cells in humans (Figure 1). 
Therefore, we suggest that HURP might have a role in maintaining the endometrium, 
although the expression pattern of HURP is different between murine and human 
endometrium. 
 We subsequently indicated that the level of HURP protein was increased by 
17β-estradiol (E2) in human endometrial stromal cells, and this suppressed the effect of 
promoting E2 expression by 4-pregnene-3,20-dione (P4). Sex steroid hormones can 
induce changes in the structure and function of the uterus and regulate menstrual cycle 
progression. Progesterone can antagonize the actions of estrogen in many ways [19–21]. 
In the previous study, HURP was shown to be induced by E2 in the mouse uterus via an 
estrogen-dependent mechanism [13]. In this study, endometrial stromal cells were 
examined for the effect of E2 and P4 on HURP expression. This study revealed that E2 
treatment continually elevated the expression of HURP protein in endometrial stromal 
cells, while P4 did not change this expression. Simultaneous administration of E2 and 
P4 offsets the effect of E2, which increased HURP (Figures 3 and 4). Therefore, this 
fact might explain why high levels of HURP expression are maintained from the late-
proliferative to the late-secretory phase of human endometrial tissue and that HURP is 
involved in embryo implantation. 
A limitation of the present study is that it has a small sample size in each of the 
subgroups. However, previously published studies using an endometrial biopsy had 
approximately 60 samples. As such, this study has a relatively large sample size. This 
study also used samples from groups that did not match the patient characteristics, such 
as age, BMI, pregnancy history, and history of infertility. However, it is very difficult to 
recruit women in all subgroups in other studies; therefore, patient characteristics have 
not been matched. In addition, to the best of our knowledge, this is the first report on 
HURP expression levels in human endometrium during various phases of the menstrual 
cycle. Inclusion of an even larger number of patients and evaluation of HURP will 
hopefully lead to safer conclusions regarding the potential etiopathogenetic role of 
embryo implantation. 
In conclusion, we showed the temporal and spatial expression of HURP in 
human endometrium. We indicated that cyclic changes in HURP expression in normal 
human ESC strongly suggest upregulation by estrogen. Given that estrogen responses 
are fundamental in both endometrial biology and female reproduction, it is possible that 
HURP is involved in these processes. The relationship between HURP expression and 
implantation failure should be explored. 
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Figure legends 
Figure 1. Immunolocalization of HURP protein in the human endometrium 
HURP protein was localized in the nucleus of the endometrial epithelial and stromal 
cells in all stages. Original magnification ×100. (A, C, E, G, I) Immunostaining with the 
primary antibody for HURP. (B, D, F, H, J) Addition of blocking peptides for HURP to 
the primary antibody for HURP. (EP, early-proliferative phase; LP, late-proliferative 
phase; ES, early-secretory phase; MS, mid-secretory phase; LS, late-secretory phase) 
 
Figure 2. Expression of HURP mRNA and protein levels in human endometrium in 
various stages of the menstrual cycle 
Endometrial tissues were divided into five groups, early-proliferative (EP), late-
proliferative (LP), early-secretory (ES), mid-secretory(MS), late-secretory (LS) phase, 
based on the endometrial tissues classified according to the last menstrual period and 
histology according to the criteria of Noyes et al. [16]. (A) Uterine HURP mRNA 
expression during the menstrual cycle was examined by quantitative RT-PCR. A 
significant increase in HURP expression level was observed during the menstrual cycle 
(＊P < 0.05, ＊＊P < 0.05 vs. EP). (B) Twenty micrograms of proteins were 
immunoblotted with a HURP polyclonal antibody (upper panel). This membrane was 
also reprobed with an anti-actin antibody, which was used as an internal control to 
indicate relative loading of the samples (lower panel). (C) Western blot was used to 
examine uterine HURP protein expression during the menstrual cycle. A significant 
increase in HURP expression level was observed during the menstrual cycle (＊P < 0.05 
vs. EP, LP, ES, and MS.). 
 
Figure 3. Effect of sex steroid hormones E2 and P4 on regulation of HURP protein 
expression 
A), B) The cells were treated with DMSO (C, negative control), E2 (10-8M), P4 (10-6M) 
and combination of E2 (10-8M) and P4 (10-6M) for 2 days and harvested 24 h following 
the final injection. C), D) The cells were treated with DMSO (C, negative control), E2 
(10-9 to -7M), P4 (10-7 to -5M) for 2 days and harvested 24 h following the final injection. 
Graphs represent the analysis of immunoblotting data. (*P < 0.05 vs. control) 
 
Figure 1 Immunolocalization of HURP protein in the human endometrium 
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Figure 4 Effect of sex-steroid hormones E2 and P4 on regulation of HURP 
protein expression 
A 
 
 
B 
 
